Suk J. Moon

Ophthalmology
250 Avenue K SW
Ste 200
Winter Haven, FL 33880

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema.

Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema.

Journal: Ophthalmology science
Published: April 01, 2021
Showing 1-1 of 1

Last Updated: 09/26/2026